InvestorsHub Logo
Followers 6
Posts 612
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Friday, 03/31/2017 8:47:30 AM

Friday, March 31, 2017 8:47:30 AM

Post# of 471824
Why no news from BIIB trials. Could it be they may want to buyout AVXL before the share price appreciates significantly this summer/fall. Given the recent MS grug approval by their competitor they have to be worried about shrinking revenue for their own flagship MS drug. Therefore, A2-73 may be a very important discussion behind the scenes at BIIB. Lets see if they make an offer tempting enough for the good Dr to accept. I say $45-$50 per share gets the deal done!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News